NeuroMetrix Ownership
| NURO Stock | USD 4.38 0.01 0.23% |
Shares in Circulation | First Issued 2003-03-31 | Previous Quarter 2 M | Current Value 2 M | Avarage Shares Outstanding 869.5 K | Quarterly Volatility 1.7 M |
NeuroMetrix |
NeuroMetrix Stock Ownership Analysis
About 15.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.56. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. NeuroMetrix recorded a loss per share of 4.51. The entity last dividend was issued on the 28th of March 2007. The firm had 1:8 split on the 22nd of November 2023. NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts. Neurometrix operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 23 people. To find out more about NeuroMetrix contact the company at 781 890 9989 or learn more at https://www.neurometrix.com.Besides selling stocks to institutional investors, NeuroMetrix also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different NeuroMetrix's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align NeuroMetrix's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
NeuroMetrix Quarterly Liabilities And Stockholders Equity |
|
NeuroMetrix Insider Trades History
About 15.0% of NeuroMetrix are currently held by insiders. Unlike NeuroMetrix's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against NeuroMetrix's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of NeuroMetrix's insider trades
NeuroMetrix Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as NeuroMetrix is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading NeuroMetrix backward and forwards among themselves. NeuroMetrix's institutional investor refers to the entity that pools money to purchase NeuroMetrix's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Fmr Inc | 2024-12-31 | 89.0 | Bank Of America Corp | 2024-12-31 | 18.0 | Harbour Investments, Inc. | 2024-12-31 | 11.0 | Citadel Advisors Llc | 2024-09-30 | 0.0 | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 0.0 | Stephens Consulting Llc | 2024-12-31 | 0.0 | Vanguard Group Inc | 2024-12-31 | 15.1 K | Mariner Wealth Advisors Llc | 2024-12-31 | 15.1 K | Geode Capital Management, Llc | 2024-12-31 | 13.2 K | Renaissance Technologies Corp | 2024-12-31 | 11.6 K | Advisor Group Holdings, Inc. | 2024-12-31 | 8.6 K |
NeuroMetrix Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific NeuroMetrix insiders, such as employees or executives, is commonly permitted as long as it does not rely on NeuroMetrix's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases NeuroMetrix insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
NeuroMetrix Outstanding Bonds
NeuroMetrix issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. NeuroMetrix uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most NeuroMetrix bonds can be classified according to their maturity, which is the date when NeuroMetrix has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| US64128XAE04 Corp BondUS64128XAE04 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
NeuroMetrix Corporate Filings
| 14th of February 2025 Other Reports | ViewVerify | |
| 13th of February 2025 Other Reports | ViewVerify | |
F4 | 5th of February 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 4th of February 2025 Other Reports | ViewVerify |
Pair Trading with NeuroMetrix
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NeuroMetrix position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeuroMetrix will appreciate offsetting losses from the drop in the long position's value.Moving together with NeuroMetrix Stock
Moving against NeuroMetrix Stock
| 0.7 | EMBC | Embecta Corp | PairCorr |
| 0.68 | ADUS | Addus HomeCare | PairCorr |
| 0.66 | DHR | Danaher | PairCorr |
| 0.58 | WST | West Pharmaceutical | PairCorr |
| 0.54 | EXAS | EXACT Sciences | PairCorr |
The ability to find closely correlated positions to NeuroMetrix could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NeuroMetrix when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NeuroMetrix - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NeuroMetrix to buy it.
The correlation of NeuroMetrix is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NeuroMetrix moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NeuroMetrix moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NeuroMetrix can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeuroMetrix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in NeuroMetrix Stock, please use our How to Invest in NeuroMetrix guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeuroMetrix. If investors know NeuroMetrix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeuroMetrix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.51) | Revenue Per Share | Quarterly Revenue Growth (0.51) | Return On Assets | Return On Equity |
The market value of NeuroMetrix is measured differently than its book value, which is the value of NeuroMetrix that is recorded on the company's balance sheet. Investors also form their own opinion of NeuroMetrix's value that differs from its market value or its book value, called intrinsic value, which is NeuroMetrix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeuroMetrix's market value can be influenced by many factors that don't directly affect NeuroMetrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NeuroMetrix's value and its price as these two are different measures arrived at by different means. Investors typically determine if NeuroMetrix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeuroMetrix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.